吗啡诱导的过敏症会影响小细胞外囊泡微RNA的组成和功能
Deepa Reddy1, Zhucheng Lin1, Sujay Ramanathan1
1Department of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
概括
慢性吗啡改变了小鼠的血清小细胞外囊泡 (sEVs) 微RNA. 这些含有特定微RNA的sEVs可以减少疼痛过敏,这表明潜在的非阿片类药物疼痛治疗.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 像吗啡这样的阿片类止痛药广泛用于疼痛管理.
- 长时间使用阿片类药物可以矛盾地增加疼痛敏感性,这种现象被称为阿片类药物诱导的过敏症.
- 驱动阿片类药物诱导的过敏症的分子机制仍然不完全理解.
研究的目的:
- 为了调查血清小细胞外囊泡 (sEVs) 的分子变化后,吗啡治疗诱导过敏症.
- 在sEV中识别特定的microRNAs (miRNAs),这些microRNAs可以调节疼痛途径.
- 评估吗啡改变的SEVs在调节疼痛敏感性的治疗潜力.
主要方法:
- 使用吗啡治疗模式在小鼠中诱导过敏症.
- 从治疗和对照小鼠的血清衍生的sEV中分析miRNA组成.
- 生物信息预测和miRNA目标的实验验证,包括CREB (循环AMP反应元素结合蛋白).
- 将sEV给原始接受者小鼠,以评估它们对 nociceptive行为的影响.
主要成果:
- 在接受了吗啡治疗的小鼠的sEV中观察到18个miRNAs的显著差异表达.
- 证实sEVs中的miR-155和miR-10a可以结合和抑制Creb mRNA.
- 内注射sEVs没有改变基底疼痛值,但加速了接受者小鼠的炎症过敏症的解决.
- 服用这些SEVs并没有影响其他行为,如有条件的位置偏好或发动机敏感性.
结论:
- 吗啡治疗改变了血清SEVs的miRNA载荷.
- 这些sEVs,特别是调节CREB表达的sEVs,显示出治疗疼痛过敏的潜力.
- 血清sEV代表了一种有前途的非阿片类药物治疗策略来治疗疼痛,并提供了对阿片类药物诱导的过敏症病理生理学的见解.
更多相关视频
05:24In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
46.5K
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.2K
相关概念视频
01:25Analgesia and Pain Management
420
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
420
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
159
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
159
01:22Opioid Receptors: Overview
420
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
420
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
203
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
203